Combined PET/CT Scanning Can Change the Management of High-Risk Cancers
|
By MedImaging International staff writers Posted on 14 Dec 2015 |
|
The results of a new study show that PET/CT and whole body MRI scanning can be used to change the management of high-risk breast and prostate cancer patients.
The study was published in the December 2015, issue of the Journal of Nuclear Medicine and indicated that Positron Emission Tomography/Computed Tomography (PET/CT) and whole-body Magnetic Resonance Imaging (MRI) could detect extra-skeletal disease and change the management of high-risk breast and prostate cancer patients. The administration of F-18 sodium fluoride (NaF) and F-18 fluorodeoxyglucose (FDG) in a single PET/CT scan also provided significantly higher accuracy, and sensitivity for the detection of skeletal lesions.
The study group consisted of patients with breast or prostate cancers and compared results of the combined use of F-18 NaF/F-18 FDG PET/CT, to those obtained with Tc-99m MDP Bone Scintigraphy (BS) and Whole-Body MRI (WBMRI). The study included 15 women with breast cancer, and 15 men with prostate cancer that had been referred for standard of care BS and subsequently underwent NaF/FDG PET/CT and WBMRI. According to the results of the preliminary study NaF/FDG PET/CT was significantly more accurate in detecting skeletal lesions than WBMRI and Tc-99m MDP scintigraphy, and NaF/FDG PET/CT and WBMRI were able to detect extra-skeletal disease, and could change the way high-risk breast and prostate cancer patients treatment are managed.
Corresponding author of the study Andrei H. Iagaru, MD, FACNM, co-chief of the Stanford University (Stanford, CA, USA) division of Nuclear Medicine and Molecular Imaging, and co-director of the PET-MRI research program, said, "Using results from previous studies, this project attempts to identify the most appropriate approach for identifying lesions in selected breast and prostate cancer patients who are at high risk of developing metastatic disease. More work remains to be done, and our group is now exploring the use of combined NaF/FDG injections with state of the art PET/MRI technology for significant decreases in radiation exposure and improved diagnostic performance in accurately evaluating extent of disease in cancer patients.”
Related Links:
Stanford University
The study was published in the December 2015, issue of the Journal of Nuclear Medicine and indicated that Positron Emission Tomography/Computed Tomography (PET/CT) and whole-body Magnetic Resonance Imaging (MRI) could detect extra-skeletal disease and change the management of high-risk breast and prostate cancer patients. The administration of F-18 sodium fluoride (NaF) and F-18 fluorodeoxyglucose (FDG) in a single PET/CT scan also provided significantly higher accuracy, and sensitivity for the detection of skeletal lesions.
The study group consisted of patients with breast or prostate cancers and compared results of the combined use of F-18 NaF/F-18 FDG PET/CT, to those obtained with Tc-99m MDP Bone Scintigraphy (BS) and Whole-Body MRI (WBMRI). The study included 15 women with breast cancer, and 15 men with prostate cancer that had been referred for standard of care BS and subsequently underwent NaF/FDG PET/CT and WBMRI. According to the results of the preliminary study NaF/FDG PET/CT was significantly more accurate in detecting skeletal lesions than WBMRI and Tc-99m MDP scintigraphy, and NaF/FDG PET/CT and WBMRI were able to detect extra-skeletal disease, and could change the way high-risk breast and prostate cancer patients treatment are managed.
Corresponding author of the study Andrei H. Iagaru, MD, FACNM, co-chief of the Stanford University (Stanford, CA, USA) division of Nuclear Medicine and Molecular Imaging, and co-director of the PET-MRI research program, said, "Using results from previous studies, this project attempts to identify the most appropriate approach for identifying lesions in selected breast and prostate cancer patients who are at high risk of developing metastatic disease. More work remains to be done, and our group is now exploring the use of combined NaF/FDG injections with state of the art PET/MRI technology for significant decreases in radiation exposure and improved diagnostic performance in accurately evaluating extent of disease in cancer patients.”
Related Links:
Stanford University
New
Mobile Cath Lab
Photon F65/F80
Radiology Software
DxWorks
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Diagnostic Ultrasound System
MS1700C
Latest MRI News
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
- First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
- New Model Improves Comparison of MRIs Taken at Different Institutions
- Groundbreaking New Scanner Sees 'Previously Undetectable' Cancer Spread
- First-Of-Its-Kind Tool Analyzes MRI Scans to Measure Brain Aging
- AI-Enhanced MRI Images Make Cancerous Breast Tissue Glow
- AI Model Automatically Segments MRI Images
- New Research Supports Routine Brain MRI Screening in Asymptomatic Late-Stage Breast Cancer Patients
- Revolutionary Portable Device Performs Rapid MRI-Based Stroke Imaging at Patient's Bedside
- AI Predicts After-Effects of Brain Tumor Surgery from MRI Scans
- MRI-First Strategy for Prostate Cancer Detection Proven Safe
- First-Of-Its-Kind 10' x 48' Mobile MRI Scanner Transforms User and Patient Experience
- New Model Makes MRI More Accurate and Reliable
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read more
Ultrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read more
Nuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read more
General/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more